|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 19, 2018 ) This report focuses on the global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations. The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
The key players covered in this study are Illumina, Roche, Agilent Technologies, Knome, Genomatix Software, GATC Biotech, Oxford Nanopore Technologies, Macrogen, Life Technologies, DNASTAR, Exosome Diagnostics, Biomatters, CLC Bio, BGI, Qiagen, Perkin Elmer, Pacific Bioscience, Partek, GnuBIO, Foundation Medicine, Paradigm, Caris Life Sciences, Myriad Genetics, and many more…
Request a sample Brochure of this report @ http://www.reportsweb.com/inquiry&RW00012214744/sample
Market segment by Type, the product can be split into
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market segment by Application, split into
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Browse Brief Report with TOC @ http://www.reportsweb.com/global-clinical-oncology-next-generation-sequencing-market-size-status-and-forecast-2018-2025
Table of Content
Global Clinical Oncology Next Generation Sequencing Market Research Report 2018-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
4.1 Global Clinical Oncology Next Generation Sequencing Market Size by Type (2013-2018)
4.2 Global Clinical Oncology Next Generation Sequencing Market Size by Application (2013-2018)
12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2013-2018)
12.1.5 Illumina Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2013-2018)
12.2.5 Roche Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2013-2018)
12.3.5 Agilent Technologies Recent Development
12.4 Knome
12.4.1 Knome Company Details
12.4.2 Company Description and Business Overview
12.4.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2013-2018)
12.4.5 Knome Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
Place Discount for complete report @ http://www.reportsweb.com/inquiry&RW00012214744/discount
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
